Broek Richard van den
CIK 1431872 · last filed 2025-08-19
Broek Richard van den is a corporate insider who has filed 66 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for PLSE, was dated Aug 19, 2025. Across all open-market trades the lifetime net is +$168.6K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
66
$168.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLSE | Director | — | $24.37 | — | $0 | 6 | 2025-08-19 |
| CRVS | Director | — | $11.93 | — | $0 | 1 | 2025-04-09 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | — | $0.07 | — | $0 | 5 | 2022-05-20 |
| RESPONSE GENETICS INC (RGDX) Delisted | Director | 282,700 | — | — | $150.0K | 7 | 2014-07-11 |
| STANDARD DIVERSIFIED INC. (SDIX) Delisted | Director | 235,630 | — | — | $18.6K | 8 | 2012-05-17 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-19 | PLSE | Grant (A) | — | $0 | EDGAR |
| 2025-04-09 | CRVS | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | PLSE | Grant (A) | — | $0 | EDGAR |
| 2023-06-06 | PLSE | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | — | Mixed | +3,750 | $0 | |
| 2022-05-23 | PLSE | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-21 | PLSE | Grant (A) | — | $0 | EDGAR |
| 2020-08-10 | PLSE | Grant (A) | — | $0 | EDGAR |